Influence of Pomegranate Juice Consumption on the Level of Antioxidants in Breast Milk

Influence of Pomegranate Juice Consumption on the Level of Antioxidants in Breast Milk

Sponsors

Lead sponsor: Hillel Yaffe Medical Center

Source Hillel Yaffe Medical Center
Brief Summary

Many medicinal effects of Pomegranate juices are already known. Mainly known for its anti-viral, anti-bacterial and anti-oxide tendency of pomegranate juice.

Many studies which have demonstrated antioxidant activity of pomegranate juice in the blood and blood cells were published.

In addition, published studies have demonstrated the anti-oxidant activity which inhibit the development of atherosclerosis and stroke, even in patients with diabetes, and its effect of decreasing systolic blood pressure in patients with systemic hypertension.

The purpose of the work is to examine the effect of drinking pomegranate juice on the level of anti-oxidants in human breast milk.

Detailed Description

the effect of pomegranate juice consumption on breast milk anti oxidants level.

Overall Status Unknown status
Start Date April 2013
Primary Completion Date April 2015
Phase N/A
Study Type Interventional
Primary Outcome
Measure Time Frame
anti oxidant level in human breast milk at least one year
Enrollment 40
Condition
Intervention

Intervention type: Dietary Supplement

Intervention name: pomegranate juice

Arm group label: 2

Eligibility

Criteria:

Inclusion Criteria:

- lactating woman

Exclusion Criteria:

- pomegranate allergy

- diabetes mellitus

- use of other Dietary Supplement

Gender: Female

Minimum age: 16 Years

Maximum age: 45 Years

Healthy volunteers: Accepts Healthy Volunteers

Verification Date

February 2013

Responsible Party

Responsible party type: Sponsor

Has Expanded Access No
Number Of Arms 1
Arm Group

Arm group label: 2

Arm group type: Experimental

Description: label I- 200 cc pomegranate juice once daily for 6 weeks post partum. label II- control group, no placebo is givening.

Study Design Info

Allocation: Randomized

Intervention model: Parallel Assignment

Primary purpose: Basic Science

Masking: None (Open Label)

Source: ClinicalTrials.gov